UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 84

Sortiert nach

Seventy years after Hench’s Nobel prize: revisiting the use of glucocorticoids in systemic lupus erythematosus

Lupus, 2020-09, Vol.29 (10), p.1155-1167

2020

Volltextzugriff (PDF)

Second week methyl-prednisolone pulses improve prognosis in patients with severe coronavirus disease 2019 pneumonia: An observational comparative study using routine care data

PloS one, 2020-09, Vol.15 (9), p.e0239401-e0239401

2020

Volltextzugriff (PDF)

Restrictive Use of Oral Glucocorticoids in Systemic Lupus Erythematosus and Prevention of Damage Without Worsening Long‐Term Disease Control: An Observational Study

Arthritis care & research (2010), 2018-04, Vol.70 (4), p.582-591

2018

Volltextzugriff (PDF)

Psychoeducational preventive treatment for women at risk of postpartum depression: study protocol for a randomized controlled trial, PROGEA

BMC psychiatry, 2017-01, Vol.17 (1), p.13-13, Article 13

2017

Volltextzugriff (PDF)

Immunosuppression use in primary antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (“Registry”)

Lupus, 2022-12, Vol.31 (14), p.1770-1776

2022

Volltextzugriff (PDF)

Glucocorticoids and antimalarials in systemic lupus erythematosus: an update and future directions

Current opinion in rheumatology, 2018-09, Vol.30 (5), p.482-489

2018

Volltextzugriff (PDF)

On line psycho-education platform to the treatment of bipolar disorder: a complementary approach

International journal of integrated care, 2016-11, Vol.16 (5), p.17

2016

Volltextzugriff (PDF)

Glucocorticoids and irreversible damage in patients with systemic lupus erythematosus

Rheumatology (Oxford, England), 2014-08, Vol.53 (8), p.1470-1476

2014

Volltextzugriff (PDF)

Comparison of high versus low–medium prednisone doses for the treatment of systemic lupus erythematosus patients with high activity at diagnosis

Autoimmunity reviews, 2015-10, Vol.14 (10), p.875-879

2015

Volltextzugriff (PDF)

Ictus, más allá del riesgo cardiovascular

Enfermedades infecciosas y microbiología clínica, 2024-05, Vol.42 (5), p.272-273

2024

Volltextzugriff (PDF)

Prolonged remission in SLE is possible by using reduced doses of prednisone: An observational study from the Lupus-Cruces and Lupus-Bordeaux inception cohorts

Autoimmunity reviews, 2019-09, Vol.18 (9), p.102359, Article 102359

2019

Volltextzugriff (PDF)

On line psycho-education: a complementary approach to the treatment of bipolar disorder

International journal of integrated care, 2016-12, Vol.16 (6), p.305

2016

Volltextzugriff (PDF)

Characteristics of Patients With Antiphospholipid Antibody Positivity in the APS ACTION International Clinical Database and Repository

Arthritis care & research (2010), 2022-02, Vol.74 (2), p.324-335

2022

Volltextzugriff (PDF)

Rituximab-refractory lupus nephritis successfully treated with belimumab

Clinical and experimental rheumatology, 2016-03, Vol.34 (2), p.355

2016

Volltextzugriff (PDF)

Anti-phospholipid antibodies do not predict damage in SLE patients in the 21st century—an observational study from the Lupus-Cruces cohort

Rheumatology (Oxford, England), 2021-12, Vol.61 (1), p.249-257

2021

Volltextzugriff (PDF)

Rituximab in antiphospholipid syndrome: always, never, sometimes?

Medicina clinica, 2015-02, Vol.144 (3), p.115

2015

Volltextzugriff (PDF)

Efficacy of Functional Remediation in Bipolar Disorder: A Multicenter Randomized Controlled Study

The American journal of psychiatry, 2013-08, Vol.170 (8), p.852-859

2013

Volltextzugriff (PDF)

Repeated pulses of methyl-prednisolone with reduced doses of prednisone improve the outcome of class III, IV and V lupus nephritis: An observational comparative study of the Lupus-Cruces and lupus-Bordeaux cohorts

Autoimmunity reviews, 2017-08, Vol.16 (8), p.826-832

2017

Volltextzugriff (PDF)

Anti–Neutrophil Extracellular Trap Antibodies in Antiphospholipid Antibody–Positive Patients: Results From the Antiphospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking Clinical Database and Repository

Arthritis & rheumatology (Hoboken, N.J.), 2023-08, Vol.75 (8), p.1407-1414

2023

Volltextzugriff (PDF)

Stroke, beyond the cardiovascular risk

Enfermedades infecciosas y microbiologia clinica (English ed.), 2024-05, Vol.42 (5), p.272-273

2024

Volltextzugriff (PDF)

Cognitive reserve in bipolar disorder: relation to cognition, psychosocial functioning and quality of life

Acta psychiatrica Scandinavica, 2016-05, Vol.133 (5), p.386-398

2016

Volltextzugriff (PDF)

The course of negative symptoms in first-episode schizophrenia and its predictors: A prospective two-year follow-up study

Schizophrenia research, 2017-11, Vol.189, p.84-90

2017

Volltextzugriff (PDF)

Factors associated with first thrombosis in patients presenting with obstetric antiphospholipid syndrome (APS) in the APS Alliance for Clinical Trials and International Networking Clinical Database and Repository: a retrospective study

BJOG : an international journal of obstetrics and gynaecology, 2019-04, Vol.126 (5), p.656-661

2019

Volltextzugriff (PDF)

1 – 25 von 84

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(76)
Mit Volltextzugriff
(78)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Seventy years after Hench’s Nobel prize: revisiting the use of glucocorticoids in systemic lupus erythematosus

Second week methyl-prednisolone pulses improve prognosis in patients with severe coronavirus disease 2019 pneumonia: An observational comparative study using routine care data

Restrictive Use of Oral Glucocorticoids in Systemic Lupus Erythematosus and Prevention of Damage Without Worsening Long‐Term Disease Control: An Observational Study

Psychoeducational preventive treatment for women at risk of postpartum depression: study protocol for a randomized controlled trial, PROGEA

Immunosuppression use in primary antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (“Registry”)

Glucocorticoids and antimalarials in systemic lupus erythematosus: an update and future directions

On line psycho-education platform to the treatment of bipolar disorder: a complementary approach

Glucocorticoids and irreversible damage in patients with systemic lupus erythematosus

Comparison of high versus low–medium prednisone doses for the treatment of systemic lupus erythematosus patients with high activity at diagnosis

Ictus, más allá del riesgo cardiovascular

Prolonged remission in SLE is possible by using reduced doses of prednisone: An observational study from the Lupus-Cruces and Lupus-Bordeaux inception cohorts

On line psycho-education: a complementary approach to the treatment of bipolar disorder

Characteristics of Patients With Antiphospholipid Antibody Positivity in the APS ACTION International Clinical Database and Repository

Rituximab-refractory lupus nephritis successfully treated with belimumab

Anti-phospholipid antibodies do not predict damage in SLE patients in the 21st century—an observational study from the Lupus-Cruces cohort

Rituximab in antiphospholipid syndrome: always, never, sometimes?

Efficacy of Functional Remediation in Bipolar Disorder: A Multicenter Randomized Controlled Study

The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort

Repeated pulses of methyl-prednisolone with reduced doses of prednisone improve the outcome of class III, IV and V lupus nephritis: An observational comparative study of the Lupus-Cruces and lupus-Bordeaux cohorts

Anti–Neutrophil Extracellular Trap Antibodies in Antiphospholipid Antibody–Positive Patients: Results From the Antiphospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking Clinical Database and Repository

Stroke, beyond the cardiovascular risk

Antiphospholipid Antibody Profile Stability Over Time: Prospective Results From the APS ACTION Clinical Database and Repository

Cognitive reserve in bipolar disorder: relation to cognition, psychosocial functioning and quality of life

The course of negative symptoms in first-episode schizophrenia and its predictors: A prospective two-year follow-up study

Factors associated with first thrombosis in patients presenting with obstetric antiphospholipid syndrome (APS) in the APS Alliance for Clinical Trials and International Networking Clinical Database and Repository: a retrospective study

Suchergebnisse filtern